Carregant...
Tissue-Targeted Complement Therapeutics
Complement activation contributes to the pathogenesis of numerous inflammatory and autoimmune diseases. Therapeutic complement inhibitors have proven effective in several of these diseases and have now entered clinical use. Complement activation has multiple different biologic effects, however, and...
Guardat en:
| Publicat a: | Mol Immunol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6146401/ https://ncbi.nlm.nih.gov/pubmed/30220307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molimm.2018.06.005 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|